NHERFs, NEP, MAGUKs, and more: Interactions that regulate PTEN

Journal of Cellular Biochemistry

Volumn 102, Issue 4, 2007, Pages 878-885

  Bonifant, Challice L ^a   Kim, Jung Sik ^a   Waldman, Todd ^a  

^a GEORGETOWN UNIVERSITY   (United States)

Author keywords

Cancer; Protein protein interactions; PTEN

Indexed keywords

MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHATASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOINOSITIDE 3,4,5 TRIPHOSPHATE; PHOSPHOINOSITOL 3 KINASE; PROTEIN KINASE B; SODIUM PROTON EXCHANGE PROTEIN; UNCLASSIFIED DRUG;

GENE MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DEPHOSPHORYLATION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PTEN GENE; REVIEW; TUMOR SUPPRESSOR GENE;

ANIMALS; HUMANS; PROTEIN BINDING; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

MAMMALIA;

EID: 35648982452     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21518     Document Type: Review

References (38)

1. Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL. 2000. Threonine phosphorylation of the MMAC1/PTEN PDZ binding domain both inhibits and stimulates PDZ binding. Cancer Res 60:35-37.
2. Caselli A, Mazzinghi B, Camici G, Manao G, Ramponi G. 2002. Some protein tyrosine phosphatases target in part to lipid rafts and interact with caveolin-1. Biochem Biophys Res Commun 296:692-697.
3. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. 2005. Crucial role of p53-dependent cellular senescence in suppression of PTEN-deficient tumorigenesis. Nature 436:725-730.
4. Chung JH, Ginn-Pease ME, Eng C. 2005. Phosphatase and tensin homologue deleted on chromosome 10 (PTEN) has nuclear localization signal-like sequences for nuclear import mediated by major vault protein. Cancer Res 65: 4108-4116.
5. Crockett DK, Fillmore GC, Elenitoba-Johnson KSJ, Lim MS. 2005. Analysis of phosphatase and tensin homolog tumor suppressor interacting proteins by in vitro and in silico proteomics. Proteomics 5:1250-1262.
6. Freeman DJ, Li AG, Wei G, Li HH, Kertesz N, Lesche R, Whale AD, Martinez-Diaz H, Rozengurt N, Cardiff RD, Liu X, Wu H. 2003. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. Cancer Cell 3: 117-130.
7. Haier J, Nicolson GL. 2002. PTEN regulates tumor cell adhesion of colon carcinoma cells under dynamic conditions of fluid flow. Oncogene 21:1450-1460.
8. Herlevsen M, Oxford G, Ptak C, Shabanowitz J, Hunt DF, Conaway M, Theodorescu D. 2007. A novel model to identify interaction partners of the PTEN tumor suppressor gene in human bladder cancer. Biochem Biophys Res Commun 352:549-555.
9. Hjelmeland AB, Hjelmeland MD, Shi Q, Hart JL, Bigner DD, Wang XF, Kontos CD, Rich JN. 2005. Loss of phosphatase and tensin homologue increases tranforming growth factor β-mediated invasion with enhanced SMAD3 transcriptional activity. Cancer Res 65:11276-11281.
10. Kim JS, Lee C, Bonifant CL, Ressom H, Waldman T. 2007. Activation of p53-dependent growth suppression in human cells by mutations in PTEN or PIK3CA. Mol Cell Biol 27:662-677.
11. Kotelevets L, van Hengel J, Bruyneel E, Mareel M, van Roy F, Chastre E. 2005. Implication of the MAGI-1b/PTEN signalosome in stabilization of adherens junctions and suppression of invasiveness. FASEB J 19:115-117.
12. + Exchanger Regulatory Factor) gene mutations in human breast cancer. Oncogene 23:8681-8687.
13. Li AG, Piluso LG, Cai X, Wei G, Sellers WR, Liu X. 2006. Mechanistic insights into maintenance of high p53 acetylation by PTEN. Mol Cell 23:575-587.
14. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. 1997. PTEN, A putative protein tyrosine phosphatase gene mutated in brain, breast, and prostate cancer. Science 275:1943-1947.
15. Lin HK, Hu YC, Lee DK, Chang C. 2004. Regulation of androgen receptor signaling by PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor through distinct mechanisms in prostate cancer cells. Mol Endo 18:2409-2423.
16. Maehama T, Dixon JE. 1998. The tumor suppressor PTEN/ MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol-3,4,5- triphosphate. J Biol Chem 273:13375-13378.
17. Mahimainathan L, Choudhury GG. 2004. Inactivation of platelet-derived growth factor receptor by the tumor suppressor PTEN provides a novel mechanism of action of the phosphatase. J Biol Chem 279:15258-15268.
18. Meuillet EJ, Mahadevan D, Berggren M, Coon A, Powis G. 2004. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: A mechanism for the functional loss of PTEN's tumor suppressor activity. Arch Biochem Biophys 429:123-133.
19. Ning K, Pei L, Liao M, Liu B, Zhang Y, Jiang W, Mielke JG, Li L, Chen Y, El-Hayek YH, Fehlings MG, Zhang X, Liu F, Eubanks J, Wan Q. 2004. Dual neuroprotective signaling mediated by downregulating two distinct phosphatase activities of PTEN. J Neurosci 24:4052-4060.
20. Okahara F, Ikawa H, Kanaho Y, Maehama T. 2004. Regulation of PTEN phosphorylation and stability by a tumor suppressor candidate protein. J Biol Chem 279:45300-45303.
21. Okumura K, Zhao M, DePinho RA, Furnari FB, Cavenee WK. 2005. Cellular transformation by the MSP58 oncogene is inhibited by its physical interaction with the PTEN tumor suppressor. Proc Natl Acad Sci 102: 2703-2706.
22. Pilarski R, Eng C. 2004. Will the real Cowden syndrome please stand up (again)? Expanding mutational and clinical spectra of the PTEN hamartoma tumour syndrome. J Med Genet 41:323-326.
23. Pinal N, Goberdhan DCI, Collinson L, Fujita Y, Cox IM, Wilson C, Pichaud F. 2006. Regulation and polarized PtdIns(3,4,5)P3 accumulation is essential for apical membrane morphogenesis in photoreceptor epithelial cells. Curr Biol 16:140-149.
24. Sanchez T, Thangada S, Wu MT, Kontos CD, Wu D, Wu H, Hla T. 2005. PTEN as an effector in the signaling of antimigratory G protein-coupled receptor. Proc Natl Acad Sci 102:4312-4317.
25. Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. 2007. Essential role for nuclear PTEN in maintaining chromosomal integrity. Cell 128:157-170.
26. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. 1997. Identification of a candidate tumour suppressor gene. MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 15:356-362.
27. Subauste MC, Nalbant P, Adamson ED, Hahn KM. 2005. Vinculin controls PTEN protein level by maintaining the interaction of the adherens junction protein β-catenin with the scaffolding protein MAGI-2. J Biol Chem 280: 5676-5681.
28. Sumitomo M, Iwase A, Zheng R, Navarro D, Kaminetzky D, Shen R, Georgescu MM, Nanus DM. 2004. Synergy in tumor suppression by direct interaction of neutral endopeptidase with PTEN. Cancer Cell 5:67-78.
29. Takahashi Y, Morales FC, Kreimann EL, Georgescu MM. 2006. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 25:910-920.
30. Tamura M, Gu J, Matsumoto K, Aota S, Parsons R, Yamada KM. 1998. Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. Science 280: 1614-1617.
31. Tamura M, Gu J, Danen EHJ, Takino T, Miyamoto S, Yamada KM. 1999. PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway. J Biol Chem 274:20693-20703.
32. Tolkacheva T, Boddapati M, Sanfiz A, Tsuchida K, Kimmelman AC, Chan AML. 2001. Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383. Cancer Res 61:4985-4989.
33. Valiente M, Anrdes-Pons A, Gomar B, Torres J, Gil A, Tapparel C, Antonarakis SE, Pulido R. 2005. Binding of PTEN to specific PDZ domains contributes to PTEN protein stability and phosphorylation by microtubule-associated serine/threonine kinases. J Biol Chem 280: 28936-28943.
34. Von Stein W, Ramrath A, Grimm A, Muller-Borg M, Wodarz A. 2005. Direct association of Bazooka/PAR-3 with the lipid phosphatase PTEN reveals a link between the PAR/aPKC complex and phosphoinositide signaling. Development 132:1675-1686.
35. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, Wood J, Ross C, Sawyers CL, Whang YE. 2000a. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci 97:4233-4238.
36. Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Lasky LA. 2000b. Interaction of the tumor suppressor PTEN/MMAC with a PDZ domain of MAGI3, A novel membrane-associated guanylate kinase. J Biol Chem 275:21477-32485.
37. Yu Z, Fotouhi-Ardakani N, Wu L, Maoui M, Wang S, Banville D, Shen SH. 2002. PTEN associates with the vault particles in HeLa cells. J Biol Chem 277:40247-40252.
38. Zhou M, Gu L, Findley HW, Jiang R, Woods WG. 2003. PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells. Cancer Res 63:6357-6362.